A new scientific review from the Center for Dementia Research on the potential benefits of marijuana in treating brain disorders says that in addition to THC and CBD produced by the cannabis plant can “demonstrate diverse pharmacological activities” and could offer therapeutic applications. Such compounds include THCV, CBDV and CBG.
“Their antioxidant, anti-inflammatory and neuromodulatory effects position them as promising agents in treating neurodegenerative disorders,” says the report, authored by a pair of researchers from the Center for Dementia Research at the Nathan Kline Institute for Psychiatric Research in New York and released last month through Preprints.org.
Epilepsy, Parkinson’s disease, Alzheimer’s disease, Huntington’s disease and substance and alcohol use disorders were all studied. They found evidence not only of neuroprotective effects but also other beneficial outcomes.
CBG in particular was seen as a strong therapeutic remedy that was used as a pain reliever and also showed positive improvements with their condition
